Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment

作者: Loredana Urso , Fiorella Calabrese , Adolfo Favaretto , PierFranco Conte , Giulia Pasello

DOI: 10.1016/J.CRITREVONC.2015.08.019

关键词:

摘要: The tumor suppressor p53 regulates genes involved in DNA repair, metabolism, cell cycle arrest, apoptosis and senescence. is mutated about 50% of the human cancers, while tumors with wild-type gene, protein function may be lost because overexpression Murine Double Minute 2 (MDM2). MDM2 targets for ubiquitylation proteasomal degradation. reactivation through inhibitors seems to a promising strategy sensitize cancer cells apoptosis. Moreover, additional p53-independent molecular functions MDM2, such as neoangiogenesis promotion, have been suggested. Thus, might target anticancer treatment its antiapoptotic proangiogenetic role. Malignant pleural mesothelioma (MPM) an aggressive asbestos-related where present. present review gives complete landscape role pathogenesis, prognosis treatment, particular focus on Pleural Mesothelioma.

参考文章(109)
Martina Schiebe, Petra Ohneseit, Wolfgang Hoffmann, R. Meyermann, Hans-Peter Rodemann, Michael Bamberg, Analysis of mdm2 and p53 gene alterations in glioblastomas and its correlation with clinical factors. Journal of Neuro-oncology. ,vol. 49, pp. 197- 203 ,(2000) , 10.1023/A:1006410702284
Andrey Korshunov, Andrey Golanov, Regina Sycheva, Immunohistochemical markers for prognosis of cerebral glioblastomas. Journal of Neuro-oncology. ,vol. 58, pp. 217- 236 ,(2002) , 10.1023/A:1016218117251
Matthias Choschzick, Uwe Heilenkötter, Annette Lebeau, Fritz Jaenicke, Luigi Terracciano, Carsten Bokemeyer, Guido Sauter, Ronald Simon, MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer Cancer Biomarkers. ,vol. 8, pp. 53- 60 ,(2011) , 10.3233/DMA-2011-0806
R Fåhraeus, V Olivares-Illana, MDM2’s social network Oncogene. ,vol. 33, pp. 4365- 4376 ,(2014) , 10.1038/ONC.2013.410
Bert Vogelstein, David Lane, Arnold J. Levine, Surfing the p53 network Nature. ,vol. 408, pp. 307- 310 ,(2000) , 10.1038/35042675
Nikolai G. Rainov, Karl-Ulrich Dobberstein, Hannes Bahn, Hans-Jürgen Holzhausen, Christine Lautenschläger, Volkmar Heidecke, Winfried Burkert, Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival Journal of Neuro-oncology. ,vol. 35, pp. 13- 28 ,(1997) , 10.1023/A:1005841520514
G Cotsonis, J J Olson, D Barnett, R Assietti, J Yang, C D James, C D James, Gene amplification as a prognostic factor in primary brain tumors. Clinical Cancer Research. ,vol. 4, pp. 215- 222 ,(1998)
Zhuo Zhang, Hui Wang, Mao Li, Sudhir Agrawal, Xinbin Chen, Ruiwen Zhang, MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53 Journal of Biological Chemistry. ,vol. 279, pp. 16000- 16006 ,(2004) , 10.1074/JBC.M312264200
M J Pajares, J Agorreta, E Salvo, C Behrens, I I Wistuba, L M Montuenga, R Pio, A Rouzaut, TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients. British Journal of Cancer. ,vol. 110, pp. 1545- 1551 ,(2014) , 10.1038/BJC.2014.33
In-San Kim, Narendra Thapa, Byung-Heon Lee, TGFBIp/βig-h3 protein: A versatile matrix molecule induced by TGF-β The International Journal of Biochemistry & Cell Biology. ,vol. 39, pp. 2183- 2194 ,(2007) , 10.1016/J.BIOCEL.2007.06.004